Skip to Main Content

Paper Details

US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER).
Genet Med
5
2022
Author NameAffiliation
Bruce D GelbMindich Child Health and Development Institute and Departments of Pediatrics and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai
Bruce D GelbMindich Child Health and Development Institute and Departments of Pediatrics and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai
Bart S FerketInstitute for Healthcare Delivery Science, Icahn School of Medicine at Mount Sinai
Lucia A Hindorff
Lucia A Hindorff
Anne SlavotinekInstitute for Human Genetics, University of California san francisco
Anne SlavotinekInstitute for Human Genetics, University of California san francisco
Jonathan S BergThe University of North Carolina at Chapel Hill
Emily Beth DevineUniversity of Washington
Hadley Stevens SmithCenter for Medical Ethics and Health Policy, Baylor College of Medicine
  • 1 - 10

Datasets